Literature DB >> 11451780

Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study.

C F Weijnen1, M E Numans, N J de Wit, A J Smout, K G Moons, T J Verheij, A W Hoes.   

Abstract

OBJECTIVES: To develop an easily applicable diagnostic scoring method to determine the presence of peptic ulcers in dyspeptic patients in a primary care setting; to evaluate whether Helicobacter pylori testing adds value to history taking.
DESIGN: Cross sectional study.
SETTING: General practitioners' offices in the Utrecht area of the Netherlands. PARTICIPANTS: 565 patients consulting a general practitioner about dyspeptic symptoms of at least two weeks' duration. MAIN OUTCOME MEASURES: The presence or absence of peptic ulcer; independent predictors of the presence of peptic ulcer as obtained from history taking and the added value of H pylori testing were quantified by using multivariate logistic regression analyses.
RESULTS: A history of peptic ulcer, pain on an empty stomach, and smoking were strong and independent diagnostic determinants of peptic ulcer disease, with odds ratios of 5.5 (95% confidence interval 2.6 to 11.8), 2.8 (1.0 to 4.0), and 2.0 (1.4 to 6.0) respectively. The area under the receiver operating characteristic curve (ROC area) of these determinants together was 0.71. Adding the H pylori test increased the ROC area only to 0.75. However, in a group of patients at high risk, identified by means of a simple scoring rule based on history taking, the predictive value for the presence of peptic ulcer increased from 16% to 26% after a positive H pylori test.
CONCLUSIONS: In the total group of dyspeptic patients in primary care, H pylori testing has no value in addition to history taking for diagnosing peptic ulcer disease. In a subgroup of patients at high risk of having peptic ulcer disease, however, it might be useful to test for and treat H pylori infections.

Entities:  

Mesh:

Year:  2001        PMID: 11451780      PMCID: PMC34540          DOI: 10.1136/bmj.323.7304.71

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  26 in total

1.  A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice.

Authors:  R Jones; C Tait; G Sladen; J Weston-Baker
Journal:  Int J Clin Pract       Date:  1999-09       Impact factor: 2.503

2.  Taking a calculated risk: predictive scoring systems in dyspepsia.

Authors:  D J Spiegelhalter; G P Crean; R Holden; R P Knill-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1987

3.  The predictive value of history in dyspepsia.

Authors:  T Johannessen; H Petersen; P M Kleveland; J H Dybdahl; A K Sandvik; E Brenna; H Waldum
Journal:  Scand J Gastroenterol       Date:  1990-07       Impact factor: 2.423

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  The meaning and use of the area under a receiver operating characteristic (ROC) curve.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

Review 6.  Disease management in ulcer disease.

Authors:  W A de Boer; E A Joosen
Journal:  Scand J Gastroenterol Suppl       Date:  1999

7.  Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial.

Authors:  A T Lassen; F M Pedersen; P Bytzer; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  2000-08-05       Impact factor: 79.321

Review 8.  Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.

Authors:  P Moayyedi; S Soo; J Deeks; D Forman; J Mason; M Innes; B Delaney
Journal:  BMJ       Date:  2000-09-16

9.  Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects: a prospective intervention study in general practice.

Authors:  E A Joosen; J H Reininga; J M Manders; J C ten Ham; W A de Boer
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-03       Impact factor: 2.566

10.  Prevalence of symptoms of dyspepsia in the community.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1989-01-07
View more
  7 in total

1.  Testing for Helicobacter pylori in dyspeptic patients. Did paper have statistical discrepancies?

Authors:  A Jacobs
Journal:  BMJ       Date:  2001-11-03

2.  Survey of general practitioners' knowledge about Helicobacter pylori infection.

Authors:  Sevgi Canbaz; Ahmet Tevfik Sunter; Yildiz Peksen; Hakan Leblebicioglu
Journal:  BMC Gastroenterol       Date:  2005-01-26       Impact factor: 3.067

3.  Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia.

Authors:  K E L McColl; L S Murray; D Gillen; A Walker; A Wirz; J Fletcher; C Mowat; E Henry; A Kelman; A Dickson
Journal:  BMJ       Date:  2002-04-27

4.  Accuracy of Helicobacter pylori serology in two peptic ulcer populations and in healthy controls.

Authors:  Rolv-Ole Lindsetmo; Roar Johnsen; Tor Jac Eide; Tore Gutteberg; Hanne Haukland Husum; Arthur Revhaug
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

5.  Complications after surgery for lumbar stenosis in a veteran population.

Authors:  Richard A Deyo; David Hickam; Jonathan P Duckart; Mark Piedra
Journal:  Spine (Phila Pa 1976)       Date:  2013-09-01       Impact factor: 3.468

6.  Surgical mortality score: risk management tool for auditing surgical performance.

Authors:  Vassilis G Hadjianastassiou; Paris P Tekkis; Jan D Poloniecki; Manolis C Gavalas; David R Goldhill
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

7.  Helicobacter pylori infection: approach of primary care physicians in a developing country.

Authors:  Shahid Ahmed; Mohammad Salih; Wasim Jafri; Hasnain Ali Shah; Saeed Hamid
Journal:  BMC Gastroenterol       Date:  2009-04-09       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.